These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 535777)

  • 21. Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women.
    Melis GB; Gambacciani M; Paoletti AM; Beneventi F; Mais V; Baroldi P; Fioretti P
    J Clin Endocrinol Metab; 1987 Sep; 65(3):541-5. PubMed ID: 3624413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of lisuride hydrogen maleate in the hyperprolactinaemia-amenorrhoea syndrome: clinical and hormonal responses.
    De Cecco L; Foglia G; Ragni N; Rossato P; Venturini PL
    Clin Endocrinol (Oxf); 1978 Dec; 9(6):491-8. PubMed ID: 106990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of 2 bromo alpha ergocryptine, quinoestrol and placebo in suppression of puerperal lactation [proceedings].
    Walker S
    Br J Clin Pharmacol; 1975 Aug; 2(4):368P-369P. PubMed ID: 788734
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of puerperal lactation by metergoline: interactions with methylergobasine maleate.
    Scapin F; Calistri D; Tronconi G; Pellicciotta G; Bareggi SR; Pontiroli AE
    Gynecol Obstet Invest; 1983; 15(3):185-90. PubMed ID: 6682072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The suppression of puerperal lactation with bromocryptine.
    Willmott MP; Colhoun EM; Bolton AE
    Acta Obstet Gynecol Scand; 1977; 56(2):145-9. PubMed ID: 324230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lisuride hydrogen maleate: evidence for a long lasting dopaminergic activity in humans.
    Liuzzi A; Chiodini PG; Oppizzi G; Botalla L; Verde G; De Stefano L; Colussi G; Gräf KJ; Horowski R
    J Clin Endocrinol Metab; 1978 Feb; 46(2):196-202. PubMed ID: 108287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral cabergoline. Single-dose inhibition of puerperal lactation.
    Caballero-Gordo A; Lopez-Nazareno N; Calderay M; Caballero JL; Mancheño E; Sghedoni D
    J Reprod Med; 1991 Oct; 36(10):717-21. PubMed ID: 1683403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel 8 alpha-ergolines with inhibitory and stimulatory effects on prolactin secretion in rats.
    Wachtel H; Dorow R; Sauer G
    Life Sci; 1984 Oct; 35(18):1859-67. PubMed ID: 6492995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of lactation with Terguride.
    Vĕtr M; Krejcí I
    Acta Univ Palacki Olomuc Fac Med; 1988; 119():347-52. PubMed ID: 2977495
    [No Abstract]   [Full Text] [Related]  

  • 30. [Inhibition of lactation with lisuride. CLinical evaluation].
    Sereno Coló JA; Navarrete Horta MT
    Ginecol Obstet Mex; 1994 Jan; 62():31-4. PubMed ID: 8168721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of lisuride [N-(D-6-methyl-8-isoergolinyl)-N',N'-diethyl-urea hydrogenmaleate] on reproductive endocrine function of women (author's transl)].
    Okamura T; Miyata R; Taniguchi I; Marumoto Y; Kamiya M; Kaibara M; Kobayashi T
    Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):489-98. PubMed ID: 6785989
    [No Abstract]   [Full Text] [Related]  

  • 32. The treatment of puerperal lactation with bromocriptine.
    Cooke I; Foley M; Lenton E; Preston E; Millar D; Jenkins A; Obiekwe B; McNeilly A; Parsons J; Kennedy G
    Postgrad Med J; 1976; 52suppl 1():75-80. PubMed ID: 959129
    [No Abstract]   [Full Text] [Related]  

  • 33. [Suppression of puerperal lactation by metergoline].
    Ohkura T; Ohya H; Hosoya N; Mori T; Watanabe H; Masaoka K; Kumasaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jan; 35(1):61-7. PubMed ID: 6827165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Terguride--a new dopamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptine.
    Ciccarelli E; Touzel R; Besser M; Grossman A
    Fertil Steril; 1988 Apr; 49(4):589-94. PubMed ID: 3127243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the ergot derivative lisuride hydrogen maleate on serum prolactin concentrations in female rats.
    Gräf KJ; Neumann F; Horowski R
    Endocrinology; 1976 Mar; 98(3):598-605. PubMed ID: 1261489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metergoline in the inhibition of puerperal lactation.
    Delitala G; Masala A; Alagna S; Devilla L; Lotti G
    Br Med J; 1977 Mar; 1(6063):744-6. PubMed ID: 322792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery.
    Giorda G; de Vincentiis S; Motta T; Casazza S; Fadin M; D'Alberton A
    Gynecol Obstet Invest; 1991; 31(2):93-6. PubMed ID: 2037265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prolactin and estrogen concentrations during drug inhibition of puerperal lactation].
    Goebel R; Rjost HK; von Werder K
    Arch Gynakol; 1975 Nov; 219(1-4):470-1. PubMed ID: 1243434
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of metoclopramide and lisuride on hypophyseal and gonadal function in men.
    Gräf KJ; Schmidt-Gollwitzer M; Horowski R; Dorow R
    Clin Endocrinol (Oxf); 1982 Sep; 17(3):243-51. PubMed ID: 6819898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled trial of bromocriptine, quinoestrol, and placebo in suppression of puerperal lactation.
    Walker S; Groom G; Davis RH; Hibbard BM; Griffiths K
    Lancet; 1975 Nov; 2(7940):842-4. PubMed ID: 53330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.